Clinical trial Recruiting at 1 site Interventional Ages 30 and up

Root canal treatment and cardiovascular risk markers in people with stable coronary artery disease

Official title: THE EFFECT OF ENDODONTIC TREATMENT ON CARDIOVASCULAR RISK BIOMARKERS IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE : A RANDOMIZED CONTROLLED TRIAL

Run by Postgraduate Institute of Dental Sciences Rohtak · NCT07343804 · Data updated 2026-11-12

This trial tests whether doing a single-visit root canal right away versus delaying it three months changes blood markers of inflammation (hs-CRP and IL-6) in people with stable coronary artery disease who have chronic apical periodontitis.

More Cardiovascular Risk Factor trials

Quick facts

Study typeInterventional
Ages30 Years and up
SexAll
Enrollment80 (estimated)
SponsorPostgraduate Institute of Dental Sciences Rohtak
Academic / other
Locations1 site (Rohtak, Haryana)
StatusRecruiting
StartedNovember 1, 2025
Main results expectedFebruary 2026
Study endsMarch 2026
Registry record updatedJanuary 15, 2026
Trial IDNCT07343804 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 30 or older with documented stable coronary artery disease and a single permanent tooth with pulp necrosis and radiographic apical periodontitis (PAI ≥3 and radiolucency ≥3 mm) are ideal candidates.

Probably not a fit

Patients without chronic apical periodontitis, those with acute or unstable coronary syndromes, or those who do not meet the specific radiographic and pulp testing criteria are unlikely to derive benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Patients with stable coronary artery disease and a single necrotic tooth with radiographic apical periodontitis were recruited from dental and cardiology outpatient clinics at PGIDS Rohtak. Baseline clinical, radiographic, and laboratory measures including hs-CRP and IL-6 were recorded. Participants were randomized to immediate single-sitting root canal treatment or to delayed endodontic treatment after three months, with clinical and laboratory reassessments at three months in both groups and an additional post-treatment measurement in the delayed group. The study compares changes in systemic inflammatory biomarkers between the two timing strategies to see if endodontic therapy affects cardiovascular risk markers.

Why it matters

Potential benefit: If successful, timely root canal treatment could lower systemic inflammation markers and potentially reduce cardiovascular risk in affected patients.

How similar studies have gone: Some small studies have reported modest reductions in systemic inflammatory markers after dental infections are treated, but the evidence specific to single-visit endodontic therapy and cardiovascular biomarkers is limited and mixed.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Individuals 30 years of age and older, with a diagnosis of stable coronary artery disease (CAD) and chronic apical periodontitis.
2. All patients had to present with CAD defined by the Brazilian Society of Cardiology (Xavier et al., 2013) as the documented occurrence of one or more of the following events 6 months before entering the study: history of myocardial infarction, stable angina or ischaemia in non-invasive tests; surgical or percutaneous myocardial revascularization and lesion size of greater than 50% in at least one major coronary artery, as assessed by angiography; presence of angina and positive results of non-invasive testing of ischaemia.
3. Presence of apical periodontitis defined by the presence of at least 1 radiographic radiolucency ( ≥ 3mm) in teeth as assessed both clinically and radiographically ,with periapical index (PAI) scores ≥3 in a single permanent tooth and pulp necrosis verified by cold and electric pulp test.

   \-

Exclusion Criteria:

1. Chronic conditions associated with periodontitis or with changes in systemic inflammation (e.g. diabetes mellitus, rheumatoid arthritis, rheumatic fever, malignancy, respiratory diseases, renal diseases).
2. Presence of localized or diffuse periodontal disease.
3. Acute symptomatic patients
4. Presence of CV risk factor - history of smoking
5. Acute conditions known to affect systemic inflammatory markers (orthopaedic trauma, surgery ,viral infections)
6. Medications (during last 3 months) known to affect systemic inflammatory markers (systemic steroids,immunosuppressants, hormone replacement therapy, contraceptives and systemic antibiotics
7. Obesity (body mass index \[BMI\]≥30 kg/m2
8. Pregnancy \& Lactation.37

Where it's running

  • Post Graduate institute of Dental Sciences, Rohtak
    Rohtak, Haryana, India
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.